Aspac Iii Acquisition CORP Form 4 insider transactions

A SPAC III Acquisition Corp. has announced a definitive merger agreement with Bioserica International Limited, a bio-based antimicrobial materials company, in a stock-for-stock transaction valued at $200 million.

A SPAC III Acquisition Corp. has entered into an agreement with Bioserica International Limited, a bio-based antimicrobial materials company, for a merger transaction valued at $200 million.

A SPAC III Acquisition Corp. has entered into an agreement with HDEducation Group Limited, a comprehensive service platform for students pursuing university education globally, for a merger transaction valued at $300 million.

A SPAC III Acquisition Corp. has announced it is exploring potential business combinations with two companies, one in education technology and the other in consumer material technology.

ASPAC III (Holdings) Corp., a significant shareholder in ASPAC III Acquisition Corp., has reported changes in its beneficial ownership, including the acquisition of Class A ordinary shares and the forfeiture of Class B ordinary shares.

Claudius Tsang, CEO and CFO of ASPAC III Acquisition Corp., reports the acquisition of 5,000 Class A ordinary shares and the forfeiture of 81,250 Class B ordinary shares.

ASPAC III (Holdings) Corp., a director of ASPAC III Acquisition Corp., purchased 280,000 Class A ordinary shares and rights, increasing its total holdings to 1,861,250 shares.

Claudius Tsang, director of ASPAC III Acquisition Corp., acquired 280,000 Class A ordinary shares through a private unit purchase.